82 related articles for article (PubMed ID: 19951460)
1. Continuous and high-level in vivo delivery of endostatin from recombinant cells encapsulated in TheraCyte immunoisolation devices.
Malavasi NV; Rodrigues DB; Chammas R; Chura-Chambi RM; Barbuto JA; Balduino K; Nonogaki S; Morganti L
Cell Transplant; 2010; 19(3):269-77. PubMed ID: 19951460
[TBL] [Abstract][Full Text] [Related]
2. Anti-tumor therapy with macroencapsulated endostatin producer cells.
Rodrigues DB; Chammas R; Malavasi NV; da Costa PL; Chura-Chambi RM; Balduino KN; Morganti L
BMC Biotechnol; 2010 Mar; 10():19. PubMed ID: 20196841
[TBL] [Abstract][Full Text] [Related]
3. Protection of xenografts by a combination of immunoisolation and a single dose of anti-CD4 antibody.
Mckenzie AW; Georgiou HM; Zhan Y; Brady JL; Lew AM
Cell Transplant; 2001; 10(2):183-93. PubMed ID: 11332633
[TBL] [Abstract][Full Text] [Related]
4. Tumor anti-angiogenic gene therapy with microencapsulated recombinant CHO cells.
Zhang Y; Wang W; Zhou J; Yu W; Zhang X; Guo X; Ma X
Ann Biomed Eng; 2007 Apr; 35(4):605-14. PubMed ID: 17277990
[TBL] [Abstract][Full Text] [Related]
5. Continuous release of endostatin from microencapsulated engineered cells for tumor therapy.
Joki T; Machluf M; Atala A; Zhu J; Seyfried NT; Dunn IF; Abe T; Carroll RS; Black PM
Nat Biotechnol; 2001 Jan; 19(1):35-9. PubMed ID: 11135549
[TBL] [Abstract][Full Text] [Related]
6. [Gene therapy of bladder cancer by using recombinant adeno-associated virus-endostatin: experiments in vitro and in vivo].
Lu BX; Han RF; Tang Y; Han YZ; Li SZ
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(12):802-5. PubMed ID: 17565858
[TBL] [Abstract][Full Text] [Related]
7. Small agarose microcapsules with cell-enclosing hollow core for cell therapy: transplantation of Ifosfamide-activating cells to the mice with preestablished subcutaneous tumor.
Sakai S; Hashimoto I; Tanaka S; Salmons B; Kawakami K
Cell Transplant; 2009; 18(8):933-9. PubMed ID: 19500478
[TBL] [Abstract][Full Text] [Related]
8. Synergistic antitumor effects of in vivo production of human endostatin and tissue inhibitor of metalloproteinase-1 in mice after subcutaneous implantation of primary fibroblasts transfected by adenovirus-mediated gene delivery.
Shen WG; Zhu J; Zhang Y; Su Q
Chin Med J (Engl); 2010 Apr; 123(7):922-8. PubMed ID: 20497689
[TBL] [Abstract][Full Text] [Related]
9. In vivo culture of encapsulated endostatin-secreting Chinese hamster ovary cells for systemic tumor inhibition.
Zhang Y; Wang W; Xie Y; Yu W; Teng H; Liu X; Zhang X; Guo X; Fei J; Ma X
Hum Gene Ther; 2007 May; 18(5):474-81. PubMed ID: 17518615
[TBL] [Abstract][Full Text] [Related]
10. Induction of angiogenesis by implantation of encapsulated primary myoblasts expressing vascular endothelial growth factor.
Springer ML; Hortelano G; Bouley DM; Wong J; Kraft PE; Blau HM
J Gene Med; 2000; 2(4):279-88. PubMed ID: 10953919
[TBL] [Abstract][Full Text] [Related]
11. Endostatin derivative angiogenesis inhibitors.
Zheng MJ
Chin Med J (Engl); 2009 Aug; 122(16):1947-51. PubMed ID: 19781376
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal studies on the microcirculation around the TheraCyte immunoisolation device, using the laser Doppler technique.
Rafael E; Gazelius B; Wu GS; Tibell A
Cell Transplant; 2000; 9(1):107-13. PubMed ID: 10784072
[TBL] [Abstract][Full Text] [Related]
13. Retroviral packaging cells encapsulated in TheraCyte immunoisolation devices enable long-term in vivo gene delivery.
Krupetsky A; Parveen Z; Marusich E; Goodrich A; Dornburg R
Front Biosci; 2003 May; 8():a94-101. PubMed ID: 12700116
[TBL] [Abstract][Full Text] [Related]
14. Transplantation of microencapsulated genetically modified xenogeneic cells augments angiogenesis and improves heart function.
Zhang H; Zhu SJ; Wang W; Wei YJ; Hu SS
Gene Ther; 2008 Jan; 15(1):40-8. PubMed ID: 17943144
[TBL] [Abstract][Full Text] [Related]
15. High-level synthesis of recombinant murine endostatin in Chinese hamster ovary cells.
Chura-Chambi RM; Tornieri PH; Spencer PJ; Nascimento PA; Mathor MB; Morganti L
Protein Expr Purif; 2004 May; 35(1):11-6. PubMed ID: 15039060
[TBL] [Abstract][Full Text] [Related]
16. Moderate antiangiogenic activity by local, transgenic expression of endostatin in Rip1Tag2 transgenic mice.
Schaffhauser B; Veikkola T; Strittmatter K; Antoniadis H; Alitalo K; Christofori G
J Leukoc Biol; 2006 Oct; 80(4):669-76. PubMed ID: 16793908
[TBL] [Abstract][Full Text] [Related]
17. [Effect of the in vitro culture and cryopreservation on the growth of the microencapsulated recombinant cell and endostatin production].
Zhang Y; Wang W; Lu GJ; Yu WT; Guo X; Xiong Y; Ma XJ
Sheng Wu Gong Cheng Xue Bao; 2007 Mar; 23(2):303-9. PubMed ID: 17460906
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of tumor growth in xenografted nude mice with adenovirus-mediated endostatin gene comparison with recombinant endostatin protein.
Liang ZH; Wu PH; Li L; Xue G; Zeng YX; Huang WL
Chin Med J (Engl); 2004 Dec; 117(12):1809-14. PubMed ID: 15603709
[TBL] [Abstract][Full Text] [Related]
19. CellMAC: a novel technology for encapsulation of mammalian cells in cellulose sulfate/pDADMAC capsules assembled on a transient alginate/Ca2+ scaffold.
Weber W; Rinderknecht M; Daoud-El Baba M; de Glutz FN; Aubel D; Fussenegger M
J Biotechnol; 2004 Nov; 114(3):315-26. PubMed ID: 15522441
[TBL] [Abstract][Full Text] [Related]
20. Intravital microscopy reveals novel antivascular and antitumor effects of endostatin delivered locally by alginate-encapsulated cells.
Read TA; Farhadi M; Bjerkvig R; Olsen BR; Rokstad AM; Huszthy PC; Vajkoczy P
Cancer Res; 2001 Sep; 61(18):6830-7. PubMed ID: 11559558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
